These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31750127)

  • 1. Cinnarizine: A Contemporary Review.
    Kirtane MV; Bhandari A; Narang P; Santani R
    Indian J Otolaryngol Head Neck Surg; 2019 Nov; 71(Suppl 2):1060-1068. PubMed ID: 31750127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.
    Scholtz AW; Hahn A; Stefflova B; Medzhidieva D; Ryazantsev SV; Paschinin A; Kunelskaya N; Schumacher K; Weisshaar G
    Clin Drug Investig; 2019 Nov; 39(11):1045-1056. PubMed ID: 31571128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study.
    Scholtz AW; Schwarz M; Baumann W; Kleinfeldt D; Scholtz HJ
    Clin Ther; 2004 Jun; 26(6):866-77. PubMed ID: 15262457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials.
    Scholtz AW; Waldfahrer F; Hampel R; Weisshaar G
    Clin Drug Investig; 2022 Sep; 42(9):705-720. PubMed ID: 35864302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Pharmacological Appropriateness of Cinnarizine and Dimenhydrinate in the Treatment of Vertigo and Related Symptoms.
    Plescia F; Salvago P; Dispenza F; Messina G; Cannizzaro E; Martines F
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33946152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study.
    Hahn A; Novotný M; Shotekov PM; Cirek Z; Bognar-Steinberg I; Baumann W
    Clin Drug Investig; 2011; 31(6):371-83. PubMed ID: 21401214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders : a randomized, reference-controlled clinical study.
    Hahn A; Sejna I; Stefflova B; Schwarz M; Baumann W
    Clin Drug Investig; 2008; 28(2):89-99. PubMed ID: 18211117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.
    Scholtz AW; Steindl R; Burchardi N; Bognar-Steinberg I; Baumann W
    Clin Drug Investig; 2012 Jun; 32(6):387-99. PubMed ID: 22506537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate versus Betahistine in the Treatment of Otogenic Vertigo : A Double-Blind, Randomised Clinical Study.
    Cirek Z; Schwarz M; Baumann W; Novotny M
    Clin Drug Investig; 2005; 25(6):377-89. PubMed ID: 17532678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice.
    Scholtz AW; Ilgner J; Loader B; Pritschow BW; Weisshaar G
    Wien Klin Wochenschr; 2016 May; 128(9-10):341-7. PubMed ID: 26659910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of vertebrobasilar insufficiency--associated vertigo with a fixed combination of cinnarizine and dimenhydrinate.
    Otto V; Fischer B; Schwarz M; Baumann W; Preibisch-Effenberger R
    Int Tinnitus J; 2008; 14(1):57-67. PubMed ID: 18616088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study.
    Teggi R; Colombo B; Gatti O; Comi G; Bussi M
    Neurol Sci; 2015 Oct; 36(10):1869-73. PubMed ID: 26037548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of cinnarizine on various types of vertigo. Clinical and electronystagmographic results of a double-blind study].
    Hausler R; Sabani E; Rohr M
    Acta Otorhinolaryngol Belg; 1989; 43(2):177-85. PubMed ID: 2690563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study.
    Taghdiri F; Togha M; Razeghi Jahromi S; Refaeian F
    Springerplus; 2014; 3():231. PubMed ID: 24834377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of Arlevert therapy for vertigo and tinnitus.
    Novotný M; Kostrica R; Círek Z
    Int Tinnitus J; 1999; 5(1):60-2. PubMed ID: 10753423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Challenges of Studying Peripheral Vestibular Vertigo.
    Naples JG
    Clin Drug Investig; 2020 Jan; 40(1):99-100. PubMed ID: 31676932
    [No Abstract]   [Full Text] [Related]  

  • 20. Authors' Reply to "The Challenges of Studying Peripheral Vestibular Vertigo".
    Scholtz AW; Weisshaar G
    Clin Drug Investig; 2020 Jan; 40(1):101-102. PubMed ID: 31679119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.